πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

65 results for β€œgranule” Clear

  1. Lifei Qingchang Granules

    The First People's Hospital of Lianyungang

    Bronchiectasis

    phase 2 small molecule active

    1 trial
  2. Pentasa Sachet 2 g depotgranulat, Pentasa PLACEBO Sachet 2g in the granule formulation specifically designed to resemble the active drug product

    The George Institute

    Lynch syndrome, which is increasing the risk of developing colorectal cancer

    phase 2 small molecule active

    1 trial
  3. Qishen Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure

    phase 2 small molecule active

    1 trial
  4. Qizhi weitong granules(HighοΌ‰

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Irritable Bowel Syndrome

    phase 2 small molecule active

    1 trial
  5. Taodan Granules

    Universal Integrated

    Psoriasis Vulgaris

    phase 2 small molecule active

    1 trial
  6. The placebo for the pantoprazole sodium 40 mg, 20 mg, 10 mg and 5 mg delayed release granules in HPMC capsules, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE

    Pfizer Australia Pty Ltd

    EROSIVE ESOPHAGITIS

    phase 2 small molecule active

    1 trial
  7. Tongjiang granule

    Universal Integrated

    Gastroesophageal Reflux

    phase 2 small molecule active

    1 trial
  8. Yougui granules

    The First People's Hospital of Lianyungang

    Renal Insufficiency, Chronic

    phase 2 small molecule terminated

    1 trial
  9. Asundexian Bayer 10mg Granules, BAY 2433334

    Bayer AG

    Prevention of thromboembolic events

    phase 1 small molecule active

    1 trial
  10. Deferitazole (disodium salt, granule)

    Takeda

    Healthy

    phase 1 small molecule terminated

    1 trial
  11. Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers

    Lacuna Pharma Pty Ltd

    No therapeutic indication in the current trial with healthy volunteers.

    phase 1 other active

    1 trial
  12. Hydrocortisone granules

    NEUROCRINE BIOSCIENCES INC

    Adrenal Insufficiency

    phase 1 small molecule completed

    1 trial
  13. Jianpi Qinghua granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nonerosive Reflux Disease

    phase 1 small molecule active

    1 trial
  14. Jiedu Tongluo granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Post-stroke Depression

    phase 1 small molecule completed

    1 trial
  15. Jiu-wei-zhen-xiao Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial
  16. Lanthanum carbonate Granule Formulation

    Takeda

    End Stage Renal Disease

    phase 1 small molecule completed

    1 trial
  17. Lofexidine (granules for reconstitution)

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. Mudan granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Peripheral Neuropathy Type 2

    phase 1 small molecule active

    1 trial
  19. WPQW granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease

    phase 1 small molecule active

    1 trial
  20. Yinhu Qingwen Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Viral Pneumonia

    phase 1 small molecule active

    1 trial
  21. shenhuang granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    phase 1 small molecule active

    1 trial
  22. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial
  23. Ornithine aspartate granule

    The First People's Hospital of Lianyungang

    Non-alcoholic Fatty Liver Disease

    approved small molecule completed

    1 trial
  24. PROGRAF 1 mg capsule, Modigraf 0.2 mg granules for oral suspension, Envarsus 0.75 mg prolonged-release tablets, PROGRAF 0,5 mg capsule, Envarsus 4 mg prolonged-release tablets, Envarsus 1 mg prolonged-release tablets, PROGRAF 5 mg capsule, Modigraf 1 mg granules for oral suspension

    Disc Medicine

    pediatric kidney transplant recipients

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources